Corbus Pharmaceuticals Holdings, Inc. Financial Ratios
CRBP|FY2022 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2022 SEC 10-K data.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2022)
Return on Equity
-66.0%
Profit Margin
-5176.4%
Net Income / Revenue
Asset Turnover
0.01
Revenue / Total Assets
Equity Multiplier
0.96
Total Assets / Equity
Composite: -66.0% (reported: -66.0%)
Profitability
Liquidity
Current Ratio
4.76
Quick Ratio
4.76
Solvency
Interest Coverage
-17.79
Efficiency
Asset Turnover
0.01
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2022 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
+2.9%
+13.7pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.